
    
      After being informed about the study and potential risk, all patients giving written informed
      consent form will be undergo a 1-week screening period to determine eligibility for study
      entry. Eligible patients will be randomly assigned to one of the two groups 1)
      electroacupuncture group: electroacupuncture will be provided to patients at BL33, BL35 and
      SP6 for 3 time per week for the first 4 weeks, then twice a week for 4 weeks, and once a week
      for the last 4 weeks. There will be 24 times of treatment in total in 3 month; 2) sham
      electroacupuncture group: sham electroacupuncture will be provided to patients at sham
      acupoints to BL33, BL35 and SP6 with the same schedule as electroacupuncture group.The
      follow-up time for the two groups are 6 months after treatment. Primary and secondary outcome
      will be measured at 3, 6, and 9 months from the start of the treatment, respectively.
    
  